Cushing's Syndrome clinical trials at UCSF
1 research study open to eligible people
Cushing's syndrome is when the body makes too much of the stress hormone cortisol. UCSF is testing how a medicine is processed and how it changes symptoms in children. UCSF is also checking for side effects and blood drug levels.
Showing trials for
(PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
open to eligible people ages 2-17
Multicenter, open-label, non-comparative study to evaluate the pharmacokinetics, pharmacodynamics, and tolerability of osilodrostat in children and adolescent patients with Cushing's syndrome.
San Francisco, California and other locations
Last updated: